Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Indias pharmaceutical ecosystem blends affordability with regulatory strength , giving distributors confidence to enter the GLP1 market with reduced risk and higher margins
doi:10.1016/S0891-5849(99)00177-X
Nevertheless, although the number of patients who had a TyG index value of 8.8 (non-insulin resistance) increased significantly in both the no/low CKD risk and CKD groups after 12 months of treatment ( Figures 3A, B ), when further stratification according to CKD severity was performed, a lower proportion of patients achieving a TyG value 8.8 was reported in the subgroup of very high CKD risk ( Figures 3CE )
However, these observational findings require careful interpretation, as they may be influenced by confounding factors such as overall health status, treatment adherence, healthcare engagement, and indication bias
US$ 28.96
US$ 26.98
US$ 22.89
US$ 29.39
US$ 20.23
US$ 20.29
US$ 25.35
US$ 25.42
US$ 29.84
US$ 26.90
US$ 24.59
